XML 76 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Operations (USD $) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
EXPENSES    
Research and development $ 2,860,658us-gaap_ResearchAndDevelopmentExpense $ 342,916us-gaap_ResearchAndDevelopmentExpense
General and administrative 4,760,145us-gaap_GeneralAndAdministrativeExpense 7,331,759us-gaap_GeneralAndAdministrativeExpense
Impairment of intangible assets 6,670,345us-gaap_GoodwillAndIntangibleAssetImpairment 1,935,621us-gaap_GoodwillAndIntangibleAssetImpairment
Gain on property damage settlement (243,592)us-gaap_GainLossRelatedToLitigationSettlement  
Fair value of common stock exchanged for warrants   3,069,792resx_FairValueOfCommonStockExchangedForWarrants
Depreciation and amortization 566,262us-gaap_DepreciationDepletionAndAmortization 116,446us-gaap_DepreciationDepletionAndAmortization
TOTAL EXPENSES 14,613,818us-gaap_OperatingExpenses 12,796,534us-gaap_OperatingExpenses
LOSS FROM OPERATIONS (14,613,818)us-gaap_OperatingIncomeLoss (12,796,534)us-gaap_OperatingIncomeLoss
OTHER EXPENSES/(INCOME)    
Gain on adjustments to fair value of derivative liability   (8,980,077)us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
Gain on extinguishment of derivative liability   (1,635,967)us-gaap_DerivativeGainLossOnDerivativeNet
Loss on settlement of notes payable - related parties 1,907,772resx_GainsLossesOnExtinguishmentOfRelatedPartyDebt  
Loss on settlement of note payable 400,016resx_GainLossOnSettlementOfNotesPayable  
Other (income) expenses (25,401)us-gaap_OtherNonoperatingIncomeExpense 660,586us-gaap_OtherNonoperatingIncomeExpense
Interest expense 273,503us-gaap_InterestExpense 126,481us-gaap_InterestExpense
TOTAL OTHER EXPENSES/(INCOME) 2,555,890us-gaap_NonoperatingIncomeExpense (9,828,977)us-gaap_NonoperatingIncomeExpense
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (17,169,708)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (2,967,557)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Benefit from income taxes 2,816,884us-gaap_IncomeTaxExpenseBenefit  
LOSS FROM CONTINUING OPERATIONS (14,352,824)us-gaap_IncomeLossFromContinuingOperations (2,967,557)us-gaap_IncomeLossFromContinuingOperations
Income from discontinued operations   503,207us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
NET LOSS (14,352,824)us-gaap_ProfitLoss (2,464,350)us-gaap_ProfitLoss
Preferred dividends   171,625us-gaap_PreferredStockDividendsIncomeStatementImpact
NET LOSS ATTRIBUTABLE TO RESTORGENEX CORPORATION (14,352,824)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (2,635,975)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Basic and diluted loss per share for continuing operations - attributable to RestorGenex Corporation (in dollars per share) $ (1.00)us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare $ (1.19)us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
Basic and diluted income per share for discontinued operations (in dollars per share)   $ 0.19us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
TOTAL BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (1.00)us-gaap_EarningsPerShareBasicAndDiluted $ (1.00)us-gaap_EarningsPerShareBasicAndDiluted
BASIC WEIGHTED AVERAGE SHARES OUTSTANDING 14,299,473us-gaap_WeightedAverageNumberOfSharesIssuedBasic 2,646,603us-gaap_WeightedAverageNumberOfSharesIssuedBasic
FULLY-DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING 14,299,473us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 2,646,603us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Net loss attributed to RestorGenex Corporation $ (14,352,824)us-gaap_NetIncomeLoss $ (2,457,949)us-gaap_NetIncomeLoss